5-(1-ethylpyrazol-4-yl)-3-(2H-indazol-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
C55H48N26O — CID 160986948
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(1-ethylpyrazol-4-yl)-3-(2H-indazol-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine
5-(1-ethylpyrazol-4-yl)-3-(2H-indazol-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine (PubChem CID 160986948) has the molecular formula C55H48N26O and a molecular weight of 1089.17 g/mol. Its IUPAC name is 5-(1-ethylpyrazol-4-yl)-3-(2H-indazol-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine.
Molecular Properties
| Compound Name | 5-(1-ethylpyrazol-4-yl)-3-(2H-indazol-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine |
|---|---|
| PubChem CID | 160986948 |
| Molecular Formula | C55H48N26O |
| Molecular Weight | 1089.17 g/mol |
| Exact Mass | 1088.45 |
| IUPAC Name | 5-(1-ethylpyrazol-4-yl)-3-(2H-indazol-3-ylmethyl)triazolo[4,5-b]pyrazine;3-(indolizin-6-ylmethyl)-5-[1-(isocyanomethyl)pyrazol-4-yl]triazolo[4,5-b]pyrazine;3-[(1S)-1-[3-(methoxymethyl)indolizin-6-yl]ethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine |
| SMILES | CCn1cc(-c2cnc3nnn(Cc4[nH]nc5ccccc45)c3n2)cn1.COCc1ccc2ccc([C@H](C)n3nnc4ncc(-c5cnn(C)c5)nc43)cn12.[C-]#[N+]Cn1cc(-c2cnc3nnn(Cc4ccc5cccn5c4)c3n2)cn1 |
| InChI | InChI=1S/C20H20N8O.C18H13N9.C17H15N9/c1-13(14-4-5-16-6-7-17(12-29-3)27(16)11-14)28-20-19(24-25-28)21-9-18(23-20)15-8-22-26(2)10-15;1-19-12-26-11-14(7-21-26)16-8-20-17-18(22-16)27(24-23-17)10-13-4-5-15-3-2-6-25(15)9-13;1-2-25-9-11(7-19-25)14-8-18-16-17(20-14)26(24-23-16)10-15-12-5-3-4-6-13(12)21-22-15/h4-11,13H,12H2,1-3H3;2-9,11H,10,12H2;3-9H,2,10H2,1H3,(H,21,22)/t13-;;/m0../s1 |
| InChIKey | TUCHCGBRENSFRH-GXKRWWSZSA-N |
| XLogP | 6.92 |
| TPSA | 274.02 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 82 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1089.17 |
| LogP ≤ 5 | 6.92 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 25 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160986948 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.